Logo

Adaptive Biotechnologies: Leslie Trigg, Katey Owen, Eric Dobmeier, and David Goel

Mar 17, 2021

Adaptive Biotechnologies announced the appointments of Leslie Trigg and Katey Owen to its board of directors. Current board members Eric Dobmeier and David Goel, who both joined the board in September 2016, will retire.

Trigg is CEO of Outset Medical, a company that makes kidney dialysis technology. She has also held executive roles at Pro-Duct Health, FoxHollow, AccessClosure, and Lutonix. Trigg holds an MBA from the University of California, Berkeley Haas School of Business.

Owen is a director at the Bill & Melinda Gates Foundation with expertise in developing biologics and vaccines at Merck. Prior to joining the pharmaceutical industry, she was an influenza researcher at the UK's National Institute for Medical Research. She holds a doctorate in molecular virology from Purdue University.

Dobmeier is president and CEO of Chinook Therapeutics and Goel is cofounder and managing general partner of Matrix Capital Management.

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.